These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7887204)

  • 41. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
    Załuga E
    Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experimental studies on the immunomodulation of Propionibacterium acnes].
    Takeuchi M
    Arerugi; 1982; 31(7):381-9. PubMed ID: 7181661
    [No Abstract]   [Full Text] [Related]  

  • 44. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.
    Pellinen P; Stenbäck F; Kojo A; Honkakoski P; Gelboin HV; Pasanen M
    Hepatology; 1996 Mar; 23(3):515-23. PubMed ID: 8617431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study on the immunostimulatory potency of different Propionibacterium strains.
    Ko HL; Roszkowski W; Jeljaszewicz J; Pulverer G
    Med Microbiol Immunol; 1981; 170(1):1-9. PubMed ID: 7300800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 47. The influence of Propionibacterium acnes (Corynebacterium parvum) fractions on immune response in vivo.
    Mára M; Julák J; Bednár M; Ocenásková J; Miková Z; Dohnalová A
    Zentralbl Bakteriol; 1994 Nov; 281(4):549-55. PubMed ID: 7727904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte proliferation and T-lymphocyte subsets during experimental immunomodulation of Balb/C mice by Olimunostim.
    Petrek M; Weigl E; Hajdúch M; Tomanová D; Spidlová A
    Acta Univ Palacki Olomuc Fac Med; 1992; 134():55-9. PubMed ID: 1364967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of tumor cells with reduced DNA content as a result of macrophage tumoricidal activity.
    Connolly KM; Kaplan AM
    Cancer Res; 1982 Jun; 42(6):2198-206. PubMed ID: 7042078
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings].
    Mullen PW
    Br J Pharmacol; 1979 Nov; 67(3):470P-472P. PubMed ID: 497584
    [No Abstract]   [Full Text] [Related]  

  • 51. Fatty acid composition of a Propionibacterium acnes vaccine and its relationship to immunostimulatory activity.
    Julák J; Bednár M; Turecek F; Mára M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):296-309. PubMed ID: 6532023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes.
    Kobayashi F; Nagoya T; Koshi T; Saino Y
    Infect Immun; 1980 Feb; 27(2):391-6. PubMed ID: 7380536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of some immunomodulators on the delayed-type hypersensitivity to nonviable Mycoplasma pulmonis in mice.
    Kishima M; Kuniyasu C; Nakagawa M
    Nihon Juigaku Zasshi; 1984 Dec; 46(6):889-91. PubMed ID: 6521151
    [No Abstract]   [Full Text] [Related]  

  • 54. Potentiation of macrophage tumor cytostasis by tumor-induced ascites.
    Gemsa D; Kramer W; Napierski I; Bärlin E; Till G; Resch K
    J Immunol; 1981 Jun; 126(6):2143-50. PubMed ID: 7229369
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pleural effusion. Local treatment by Corynebacterium parvum].
    Serrou B; Cupissol D
    Nouv Presse Med; 1980 Jun; 9(25):1777-8. PubMed ID: 7383874
    [No Abstract]   [Full Text] [Related]  

  • 56. Macrophage functional heterogeneity.
    Walker WS
    Adv Exp Med Biol; 1982; 155():435-43. PubMed ID: 7158494
    [No Abstract]   [Full Text] [Related]  

  • 57. Anaerobic coryneforms isolated from human bone marrow and skin. Chemical, biochemical and serological studies and some of their biological activities.
    Saino Y; Eda J; Nagoya T; Yoshimura Y; Yamaguchi M
    Jpn J Microbiol; 1976 Feb; 20(1):17-25. PubMed ID: 1271588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical aspects of immunomodulation by Propionibacterium acnes.
    Hajdúch M; Weigl E; Jezdínská V; Zpĕvácková L
    Acta Univ Palacki Olomuc Fac Med; 1993; 136():9-12. PubMed ID: 7887204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some biochemical characteristics of the early phase of immunomodulation.
    Hajdúch M; Weigl E; Jezdinská V; Budíková M; Zpĕvácková L
    Acta Univ Palacki Olomuc Fac Med; 1994; 137():39-43. PubMed ID: 7778504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of serum IL-18 with Propionibacterium acnes and lipopolysaccharide in phagocytic macrophage-inactivated mice.
    Nishioka T; Kuroishi T; Sugawara Y; Yu Z; Sasano T; Endo Y; Sugawara S
    J Leukoc Biol; 2007 Aug; 82(2):327-34. PubMed ID: 17522234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.